Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Nutraceutical Excipients Market is expected to hit USD 6.6 Bn by 2029 at a CAGR of 6.97 percent – says Maximize Market Research

Published

on

<!– Name:DistributionId Value:8842193 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value: –> <!– Name:CustomerId Value:1267597 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:c327634a-7ab9-48b0-a8f5-96fd7ed51fbf –>

Pune, May 18, 2023 (GLOBE NEWSWIRE) — Maximize Market Research, a global healthcare research and business-consulting firm has recently released a comprehensive market intelligence report titled “Nutraceutical Excipients Market” The report offers a conscientious analysis of the Nutraceutical Excipients Market using a combination of primary and secondary data sources and insights from domain experts. It presents a comprehensive outlook of the market at both regional and global levels. According to Maximize Market Research, the Nutraceutical Excipients Market is expected to exhibit a robust growth trajectory, with the market value expected to increase from USD 4.12 billion in 2022 to USD 6.6 billion by 2029, representing a notable compound annual growth rate of 6.97 percent over the forecast period.

Nutraceutical Excipients Market Report Scope and Research Methodology

Market Size in 2022 USD 4.12 Bn.
Market Size in 2029 USD 6.6 Bn.
CAGR 6.97 percent (2023-2029)
Forecast Period 2023-2029
Base Year 2022
Number of Pages 273
No. of Tables 114
No. of Charts and Figures 113
Segment Covered Type and Form, and Application
Regional Scope North America, Europe, Asia Pacific, Middle East and Africa, South America
Report Coverage Market Share, Size & Forecast by Revenue | 2022−2029, Market Dynamics, Growth Drivers, Restraints, Investment Opportunities, and Key Trends, Competitive Landscape, Key Players Benchmarking, Competitive Analysis, MMR Competition Matrix, Competitive Leadership Mapping, Global Key Players’ Market Ranking Analysis.

Request For Free Sample Report : https://www.maximizemarketresearch.com/request-sample/187544

• Nutraceutical Excipients Market report consists of quantitative Analysis such as analyzing numerical data such as production volumes, market size, and growth rates to identify patterns and trends. In addition, qualitative analysis involves non-numerical data such as consumer preferences, market perception, and industry trends to gain insights into the market.

Advertisement
Stake.com

• Primary research involves gathering data through primary sources such as interviews with industry experts, company representatives, and end-users to gain insights into the market dynamics, demand, and supply patterns, and emerging trends. Secondary Research involves gathering data from secondary sources such as reports, company websites, industry journals, and government publications to estimate market size and market shares.

• The report is carved using analytical tools such as SWOT analysis, Porter’s Five Forces analysis, and PESTEL analysis used to conduct the market analysis. This report provides a 360-degree aspect of the Nutraceutical Excipients Market.

Nutraceutical Excipients Market Overview

Autologous hematopoietic stem cell transplantation is a medical procedure wherein a patient receives healthy blood-forming cells (stem cells) from a donor to replace their own stem cells that have been compromised or destroyed due to radiation treatment or high doses of chemotherapy. The process involved extensive collection of primary and secondary data from diverse sources, such as industry experts, therapists, medical journals, regulatory bodies, and company reports. Rigorous analysis of the collected data was conducted utilizing various statistical tools and techniques, encompassing both quantitative and qualitative assessments of the market. This analysis entailed evaluating the market size, growth rate, market share, and market trends. To predict the future growth of the Nutraceutical Excipients market, historical data was meticulously examined alongside an analysis of prevailing market trends and growth drivers. Additionally, the report provides a comprehensive examination of the competitive landscape of the Nutraceutical Excipients market, encompassing market share, competitive strategies, and product portfolios of key market players.

Get a Sample Copy of the Report : https://www.maximizemarketresearch.com/request-sample/187544

Advertisement
Stake.com

Nutraceutical Excipients Market Dynamics

The global Nutraceutical excipients market is expected to experience high growth during the forecast period, thanks to the increasing demand for functional and fortified food products that cater to consumers’ nutritional requirements. As the market becomes more health-conscious, and seeking food items that provide additional health advantages. This growing trend is expected to drive the demand for nutraceutical excipients, which are essential ingredients utilized in the production of functional products. Another factor boosting the growth of the market is the rising demand for preventive healthcare. With the prevalence of chronic diseases like obesity, diabetes, and heart disease continuing to rise. Also, an increasing number of people turning to their functional foods as dietary supplements and functional foods are anticipated to grow.

The global nutraceutical excipients market presents several opportunities such as increasing demand for clean-label and plant-based products. As consumers become more health conscious, they are progressively looking for food products devoid of artificial additives and preservatives. This trend is expected to drive the demand for the nutraceutical market. The current market customer base is getting increasingly aware of their nutritional need and seeking personalized nutrition to fulfill their requirements. This will be a major boost and is expected to create new opportunities in the market. Another key point for nutraceutical excipient manufacturers is the development of more efficient and cost-effective production processes, which can be achieved by reducing production costs, profitability, etc.

The regulatory framework governs the use of nutraceutical excipients, as the ingredients are incorporated into products intended for human consumption. In addition, compliance with these regulations is time-consuming and expensive, limiting market entry and growth opportunities. Also the availability and cost of raw materials, as the availability susceptible to factors like weather conditions, environmental changes, and geopolitical issues. Consequently, the fluctuations in the cost and supply of raw materials rise major constraints for the market. The global nutraceutical excipients market also faces several challenges and heavy competition from alternative ingredients such as probiotics, prebiotics, and enzymes. The lack of standardization and quality control poses a significant challenge for the nutraceutical excipients market.

Nutraceutical Excipients Market Regional Insights

Advertisement
Stake.com

North America and Europe are the primary markets for nutraceutical excipients, constituting a substantial portion of the global market. The market in regions is primarily driven by several factors, including the escalating prevalence of chronic diseases, growing demand for organic and natural products, and the availability of advanced technology for nutraceutical product manufacturing.

The Asia Pacific region is projected to exhibit the highest growth rate throughout the forecast period. The growth is attributed to the increasing awareness regarding health benefits associated with nutraceutical products, the presence of a substantial population base, rapid urbanization, and heightened investments in the healthcare sector contribute to the growth of the Asia Pacific region.

Get Customization on this Report for Specific Research Solutions: https://www.maximizemarketresearch.com/request-customization/187544

Nutraceutical Excipients Market Segmentation

By Type:

Advertisement
Stake.com
  • Binders
  • Fillers & Diluents
  • Disintegrants
  • Coating Agents
  • Flavouring Agents & Sweeteners
  • Lubricants
  • Others

By Form:

  • Dry Excipients
  • Liquid Excipients        

By Application:

  • Dietary Supplements
  • Functional Foods
  • Pharmaceuticals

Dietary supplements are the largest segment, followed by functional foods and pharmaceuticals. The demand for dietary supplements is driven by the increasing prevalence of chronic diseases and the growing awareness regarding the health benefits of nutritional supplements.

Key Competitors include:

  • Ashland Global Holdings Inc. (US)
  • DuPont (US)
  • Ingredion Incorporated (US)
  • Archer Daniels Midland Company (US)
  • Sensient Technologies Corporation (US)
  • BASF SE (Germany)
  • Brenntag AG (Germany)
  • Evonik Industries AG (Germany)
  • Lonza Group Ltd. (Switzerland)
  • Roquette Frères (France)
  • Kerry Group PLC (Ireland)
  • Tate & Lyle plc (UK)
  • Associated British Foods plc (UK)
  • IMCD BV (Netherlands)
  • Corbion NV (Netherlands)
  • Ajinomoto Co., Inc. (Japan)
  • Huachang Group Co., Ltd. (China)
  • Jubilant Life Sciences Limited (India)
  • SABIC (Saudi Arabia)
  • Gulf Pharmaceutical Industries (Kuwait)
  • Al-Kharafi Group (Kuwait)
  • ADM do Brasil Ltda. (Brazil)
  • Ingredion Brasil Ltda. (Brazil)
  • Kerry Ingredients do Brasil Ltda. (Brazil)
  • Raízen Energia S.A. (Brazil)
  • Ezz Dekheila Company for Food Industries (Egypt)

The nutraceutical excipients market structure creates a highly competitive environment, with players competing on price, quality, and innovation to gain a larger market share. DuPont acquired Colorcon, a supplier of colorants and specialty ingredients for the food, beverage, and pharmaceutical industries. This acquisition gives DuPont a strong position in the nutraceutical excipients industry, as Colorcon used in a wide range of nutraceutical products. Also in 2023, Kerry Group acquired Ingredion’s Health & Nutrition business, which helps Kerry Group to get the leading position in the nutraceutical excipients market.

Get the Sample PDF of Report: https://www.maximizemarketresearch.com/request-sample/187544

Key questions answered in the Nutraceutical Excipients Market are:

  • What was the Nutraceutical Excipients Market size in 2022?
  • What is the Nutraceutical Excipients Market?
  • What is the expected Nutraceutical Excipients Market size during the forecast period?
  • Which region dominates the largest market share in the Nutraceutical Excipients Market?
  • What are the global trends in the Nutraceutical Excipients Market?
  • What are the major restraints for the Nutraceutical Excipients Market?
  • What are the upcoming industry applications and trends for the Nutraceutical Excipients Market?
  • Which segment dominated the Nutraceutical Excipients Market growth?
  • What is the demand pattern for the Nutraceutical Excipients Market?
  • Nutraceutical Excipients Market?
  • Who are the leading companies and what are their portfolios in Nutraceutical Excipients Market?
  • What growth strategies are the players considering to increase their presence in

Key Offerings:

  • Past Market Size and Competitive Landscape (2018 to 2021)
  • Past Pricing and price curve by region (2018 to 2021)
  • Market Size, Share, Size & Forecast by different segment | 2022−2029
  • Market Dynamics – Growth Drivers, Restraints, Opportunities, Organization Size, Application, and Industry Vertical
  • Market Segmentation – A detailed analysis by Type, Form, and Application
  • Competitive Landscape – Profiles of selected key players by region from a strategic perspective
    • Competitive landscape – Market Leaders, Market Followers, Regional player
    • Competitive benchmarking of key players by region
  • PESTLE Analysis
  • PORTER’s analysis
  • Value chain and supply chain analysis
  • Legal Aspects of Business by Region
  • Lucrative business opportunities with SWOT analysis
  • Recommendations

Maximize Market Research is leading Healthcare research firm, has also published the following reports:

Nutraceutical MarketThe market size is expected to reach USD 303.25 Bn by 2029 at a CAGR of 7.2 percent during the forecast period. The market is expected to be driven by a growing global burden of chronic illnesses.

Functional Beverages Market The market size is expected to reach USD 233.25 Bn by 2029 at a CAGR of 7.47 percent during the forecast period. The market is expected to be driven by increased consumer health awareness, demand for convenient beverage options, and growth in disposable income.

Advertisement
Stake.com

Nutrition Product Market The market size is expected to reach USD 622.7 Bn by 2029 at a CAGR of 6.4 percent during the forecast period. The market is expected to be driven by nutrition products that cater to a wide range of health concerns, from weight management to overall wellness.

Collagen and Gelatin Market– The market size is expected to reach USD 1480 Bn by 2029 at a CAGR of 7.8 percent during the forecast period. The rising prevalence of Osteoporosis among individuals is driving the growth of the market.

Collagen Supplements Market The market size is expected to reach USD 3.54 Bn by 2029 at a CAGR of 6.9 percent during the forecast period. One-third or 38% of people have shifted gradually towards the health and wellness sector which is the major driver for the market.

About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology, and communication, cars, and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

Advertisement
Stake.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

MGI Tech and SeqOne Partner to Advance End-to-end Genomic Analysis

Published

on

mgi-tech-and-seqone-partner-to-advance-end-to-end-genomic-analysis

PARIS, June 17, 2024 /PRNewswire/ — MGI (MGI Tech Co., Ltd. or its subsidiaries, together referred to MGI), a company committed to building core tools and technologies that drive innovation in life science, today announced the collaboration with SeqOne, a leading provider of AI-driven genomic decision support software, to develop and validate end-to-end genomic analysis solutions from sample to report tailored to the needs of Human Genetics and Pathology labs worldwide.

This collaboration between MGI and SeqOne encompasses three distinct initiatives:
Validating an end-to-end, automated, cost-effective solution for HRD signature with MGI DNBSEQ-G99
The collaboration between a Pathology Reference Lab in Spain, Agilent Technologies, MGI, and SeqOne aims to technically validate a routine workflow leveraging Agilent panels, Magnis lib prep automation, MGI DNBSEQ-G99, and SeqOne somaHRD, a clinically validated HRD signature solution, on 96 samples.
This end-to-end solution for pathology molecular labs will enable high-quality, efficient, and flexible HRD testing worldwide, including Genomic Instability score and BRCA testing.
Enabling and validating SeqOne tertiary analysis solution compatible with MGI Megabolt for Germline Panels, Whole Exome and Whole Genome
MegaBOLT bioinformatics analysis accelerator, self-developed and MPS-concentrated hardware accelerating system by MGI, is set to ensure seamless integration and compatibility with SeqOne’s AI-powered variants identification and analysis solution.
The collaboration aims to combine MegaBOLT and the SeqOne Platform to deliver a versatile, cost-effective, intuitive, and time-saving solution from sample to report, particularly attractive for high-throughput Human Genetics labs.
Validating SeqOne CE-IVD Platform for Germline and Somatic analysis for use with MGI sequencers in routine diagnostics
This technical validation project aims to evaluate the compatibility of the SeqOne Platform with MGI sequencing data. It will validate variant calling performances on a set of reference control samples in terms of QC, sensitivity and precision.
“We are thrilled to announce our collaboration with SeqOne. By combining MGI’s cutting-edge sequencing technology with SeqOne’s innovative genomic analysis Platform, we are poised to deliver real insights and solutions for personalized healthcare,” said Dr. Yong Hou, General Manager of MGI Europe and Africa. “This collaboration underscores our commitment to advancing genomic research and providing clinicians with the tools they need to offer tailored treatments to their patients.”
“This partnership with MGI strongly supports SeqOne’s mission to broaden access to sophisticated genomic analysis, aiming to improve healthcare outcomes,” said Martin Dubuc, CEO, SeqOne. “Molecular laboratories globally are exploring how MGI’s sequencing and bioinformatics technologies can advance next-generation sequencing (NGS) research and diagnostics. We are eager to integrate SeqOne’s CE-IVD Platform with MGI’s offerings, enhancing the quality, sensitivity, and precision of bioinformatic analyses.”
About MGI
MGI Tech Co., Ltd. (or its subsidiaries, together referred to MGI) is committed to building core tools and technologies that drive innovation in life science. Our focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare and various other industries. Founded in 2016, MGI has grown into a leader in life science, serving customers across six continents and have established research, manufacturing, training, and after-sales service facilities globally. MGI stands out as one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers with varying throughput capacities, ranging from Gb to Tb levels. With unparalleled expertise, cutting-edge products, and a commitment to global impact, MGI continues to shape the trajectory of life sciences into the future. To learn more, please visit https://en.mgi-tech.com/, LinkedIn, X, and YouTube.
About SeqOne
SeqOne is a fast-growing deep-tech company focused on turning genomic data into medically- actionable insights in oncology and rare and inherited diseases. Our vision is to make personalized healthcare a reality for every patient, everywhere. We are committed to democratizing access to advanced genomic insights, enabling labs of any size, in any location, to offer affordable personalized medicine solutions to patients at scale. We integrate cutting-edge AI and big data technologies to redefine genetic data analysis. Our CE-IVD Platform provides time saving, flexible, and cost-effective decision support, empowering decentralized laboratories worldwide to deliver precision diagnostics.The company has won numerous awards, including the iLab award and the ARC Cancer Foundation’s Hélène Stark prize. Investors include Elaia, IRDI Capital Investissement, Merieux Equity Partners, Omnes, and Software Club. To learn more, please visit www.seqone.com and Linkedin.
Logo – https://mma.prnewswire.com/media/2329841/MGI__Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/mgi-tech-and-seqone-partner-to-advance-end-to-end-genomic-analysis-302173987.html

Continue Reading

Artificial Intelligence

Symphony Talent’s Award-Winning Full-Funnel Talent Acquisition Portfolio Earns Strategic Challenger Status on Fosway 9-Grid™ for Third Consecutive Year

Published

on

symphony-talent’s-award-winning-full-funnel-talent-acquisition-portfolio-earns-strategic-challenger-status-on-fosway-9-grid™-for-third-consecutive-year

NEW YORK and LONDON, June 17, 2024 /PRNewswire/ — Symphony Talent, a global leader in recruitment marketing technology and employer brand services, has been named a Strategic Challenger on the 2024 Fosway 9-Grid™ for Talent Acquisition for the third consecutive year, demonstrating Symphony Talent’s consistent dedication to providing cutting-edge solutions that drive game-changing results for talent acquisition teams worldwide.

“From rapidly evolving technologies to shifting candidate expectations, the TA industry faces many challenges,” says Sven Elbert, Head of Analyst Services at Fosway Group. “A full-funnel talent acquisition solution — that seamlessly aligns employer branding, technology and data analytics to the candidate journey — is essential to address these complexities. Symphony Talent provides a robust framework for meeting the diverse needs of complex, global enterprise-scale clients.”
Empowering TA Teams with Full-Funnel Solutions
Symphony Talent’s extensive portfolio of talent acquisition solutions, including its Brand and Creative Services, Programmatic Media Advertising, Career Sites, CRM, and Assessments, drive outstanding client results by addressing every stage of the talent acquisition funnel. Over 700 global clients leverage Symphony Talent’s innovative technologies and strategic expertise, achieving significant outcomes, such as:
Cutting administrative recruiting tasks by 65%Spending 70% less time managing media spendReducing time spent qualifying talent by 60%Decreasing cost per hire by 25%Filling open positions 30% fasterEnsuring quality hires with a 15% reduction in employee turnover”We are honored to be recognized as a Strategic Challenger on the Fosway 9-Grid™ for the third year in a row,” says Kermit Randa, CEO of Symphony Talent. “This achievement highlights our ongoing commitment to connect clients with innovative, high-impact solutions and data that empower them to navigate the complexities of today’s talent landscape and confidently convert candidates to co-workers.”
Highlights of Symphony Talent’s Achievement:
Innovation and Leadership: Symphony Talent’s continuous recognition as a Strategic Challenger is a testament to its unwavering commitment to innovation and leadership in the talent acquisition industry. The company’s comprehensive suite of solutions, including the award-winning SFX platform, integrates brand and creative services with recruitment marketing technology to streamline the hiring process and enhance candidate experience.Client-Centric Approach: Symphony Talent’s focus on understanding and addressing its clients’ evolving needs has been pivotal in maintaining its strategic position. Symphony Talent ensures clients achieve tangible and measurable outcomes by offering personalized support, detailed implementation schedules, and optimization workgroups.Adaptation to Market Trends: With a deep understanding of the current market dynamics and the challenges faced by talent acquisition teams, Symphony Talent has continuously adapted its offerings to meet these demands. This includes leveraging AI and automation to enhance productivity and providing data-driven insights to optimize recruitment strategies.About the Fosway 9-Grid™
Fosway Group is Europe’s #1 HR industry analyst. The Fosway 9-Grid™ provides a unique assessment of the principal learning and talent supply options available to organisations in EMEA. The analysis is based on extensive independent research and insights from Fosway’s Corporate Research Network of over 250 organisations, including BP, HSBC, PwC, RBS, Sanofi, Shell, and Vodafone. Visit the Fosway website at www.fosway.com.
About Symphony Talent
Symphony Talent is a recruitment marketing technology and employer brand services company that helps talent acquisition teams execute strategic, innovative candidate interactions. Our award-winning, synergistic technology and brand solutions are designed to deliver outcomes — from reach to retention — that unlock a competitive advantage for clients across the globe, including the world’s leading brands. Visit symphonytalent.com to learn more.
Logo – https://mma.prnewswire.com/media/2287879/ST_Logo_Single_Line_Full_Color__12_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/symphony-talents-award-winning-full-funnel-talent-acquisition-portfolio-earns-strategic-challenger-status-on-fosway-9-grid-for-third-consecutive-year-302173377.html

Continue Reading

Artificial Intelligence

Darwinbox named as a Customers’ Choice in the 2024 Gartner® Peer Insights™ Voice of the Customer for Cloud HCM Suites Report for Enterprises with 1,000+ Employees

Published

on

darwinbox-named-as-a-customers’-choice-in-the-2024-gartner-peer-insights™-voice-of-the-customer-for-cloud-hcm-suites-report-for-enterprises-with-1,000+-employees

DUBAI, UAE, June 17, 2024 /PRNewswire/ — Darwinbox, a global leader in cloud-based HCM solutions, today announced that it has been distinguished as a Customers’ Choice in the 2024 Gartner® Peer Insights™ Voice of the Customer for Cloud HCM Suites for 1,000+ Employee Enterprises.

The Gartner® Peer Insights™ Customers’ Choice distinction is based on feedback and ratings from end-user professionals with experience using the product or service. As of 31 January 2024, Darwinbox received an overall rating of 4.8 out of 5 stars across 141 reviews.
“We believe this distinction, for the third consecutive year, reflects our unwavering commitment to our customers and their success, as well as our dedication to excellence and innovation in the HCM space,” says Jayant Paleti, co-founder, Darwinbox.
Darwinbox has been named a Customers’ Choice for both Large Enterprise (1B – 10B USD) and Midsize Enterprise (50M – 1B USD) segments, showcasing its robust capabilities in handling large-scale operations and its widespread appeal across various business sizes. This recognition underscores the platform’s popularity, driven by its powerful configurability, intuitive design, and agility. An impressive 98% of customers rated Darwinbox 4-stars or higher, highlighting the overwhelming satisfaction with the product.
Furthermore, Darwinbox is recognized as the most customer-friendly enterprise-grade HCM solution globally. The platform distinguishes itself through its ease of implementation and integration, prompt vendor responses, and exceptional technical support, demonstrating Darwinbox’s dedication to quick service and client satisfaction. Notably, 94% of its customers have expressed their willingness to recommend Darwinbox, demonstrating its significant impact and reliability in the enterprise tech landscape.
“What I love is when we need support, the customer service is top-notch – always responsive, solution makers, and always helpful,” HR Business Partner, Media Industry
“Darwinbox has been able to cater to our needs given our diverse business structures and differences in processes,” HR Lead, Manufacturing Sector
Read more reviews
About Darwinbox:
Darwinbox is a leading SaaS-based HR technology platform, empowering organisations to automate HR processes and elevate the employee experience. Rated the highest globally among HCM players on Gartner’s customer review platform, Peer Insights, Darwinbox is trusted by 900+ global enterprises with more than 2.5 million employees spread across 116+ countries.
Photo: https://mma.prnewswire.com/media/2438686/Darwinbox_Voice_of_the_Customer.jpg

View original content:https://www.prnewswire.co.uk/news-releases/darwinbox-named-as-a-customers-choice-in-the-2024-gartner-peer-insights-voice-of-the-customer-for-cloud-hcm-suites-report-for-enterprises-with-1-000-employees-302173015.html

Continue Reading

Trending